Private equity firm HIG Capital has recapitalised United States Medical Supply (US MED), a direct-to-consumer mail-order medical supply business, focused on patients with chronic conditions, in partnership with management.
Headquartered in Miami, FL, US MED provides medical supplies to patients suffering from chronic conditions, including diabetes, sleep/respiratory disorders, and urological conditions who need such supplies daily. US MED is among the largest and most efficient direct-to-consumer providers of medical supplies in the nation, with a best-in-class IT, compliance, and operating platform. The Company provides a compelling value proposition to all healthcare constituents, including patients, payers, physicians, and manufacturers. US MED delivers outstanding customer service and quality medical supplies to patients in order to help them effectively control their conditions and improve the quality of their lives.
Founder and CEO, Zachary Schiffman says: “We are thrilled to partner with HIG – they have a strong history of working with healthcare and founder-owned companies to accelerate growth and increase value to patients. I started US MED almost 20 years ago with the mission to provide ‘better service and better care’ for patients with chronic conditions while recognising the need to reduce healthcare costs throughout the system. I believe we have done that and will strive for US MED to be even more impactful with HIG as a partner.”
Camilo E Horvilleur (pictured), Managing Director at HIG Capital, says: “We identified US MED as an industry leader with a proven track record, patient-centric model, incredibly efficient operating platform, and a talented metrics-driven management team. We are excited to partner with Zachary and management to support their strategic growth plan, particularly by aggressively pursuing value-enhancing add-on acquisitions.”
